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Clinical Significance of Sleep Desaturation in Hypoxemic Chronic
Obstructive Pulmonary Disease: Studies in 130 Patients
William A. Conway, MD,* Meir Kryger, MD,+ Richard M. Timms, MD,* and
George W. Williams, MD§

We studied 130 patients with hypoxemic chronic obstructive lung disease to delermine if nocturnal
desaturation aggravates hypoxia-induced complications. All had tesls of neuropsychological and
physiological function known to be affected by chronic hypoxia. Ofthe 130 patients, 25 had complete
polysomnography and 105 had their sleep judged visually and arterial oxygen saturation recorded
continuously. Severe and mild desaturation groups were defined relative to the mean for both mean and
maximal sleep desaturation, and the severity of waking complications were compared. No significant
differences were noled between patients wilh mild and severe mean desaturation or maximal
desaturation for hematocrit, neuropsychological tests, maximal exercise tolerance, or measures of
quality of life. Waking pulmonary artery pressure did not differ significanlly ber^'een patients with mild
and severe mean desaturation or maximal desaturation, except in 20 patients with the mosl severe
mean desaturation during sleep. We conclude lhal nocturnal desaturation does not aggravate
hypoxia-induced complications in most patients who are chronically hypoxemic from chronic
obstructive pulmonary disease. (Henry Ford Hosp Med J 1988:36:16-23)

A

rterial oxygen desaturation occurs frequently during sleep in
patients with chronic obstmctive pulmonary disease (COPD)
(1-7). In some patients, episodes of hypoxemia during sleep are
prolonged and severe. Causes of hypoxemia include hypoventilation (2,6) and, rarely, episodes of upper airway obstmction
and central apnea (5,7). Frequently, hypoxemia may occur without any abnormalities in breathing pattems, suggesting alterations in the distribution of ventilation perfusion ratios (1,6).
Although desaturation has been well described and appears to
be common, its clinical significance is unclear. Episodes of desaturation are accompanied by transient elevations in pulmonary
artery pressure (8,9), but sustained pulmonary hypertension and
cor pulmonale have not been causally linked to episodes of sleep
desaturation. Furthermore, the effect of noctumal desaturation
on other complications of hypoxia, such as polycythemia, neuropsychological impairment, and exercise intolerance, has not
been evaluated. To examine the role of sleep desaturation on hypoxemia-induced complications, we monitored continuously arterial oxygen saturation (SaO,) during sleep in a well-defined
population of patients with severe hypoxemic COPD. Our purpose was to determine i f patients with severe noctumal desaturation had more severe complications of chronic hypoxemia than
those with less severe desaturation and whether routine clinical
and laboratory features might offer clues to the presence of
severe sleep desaturation.

Methods
Patients
From the 203 hypoxemic patients enrolled in a multicenter
noctumal oxygen therapy trial (NOTT), data on 130 who slept
for more than two hours were selected for analysis. Complete
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entry criteria and methods for the NOTT have been previously
published (10). All patients had a history compatible with COPD
and a forced expiratory volume in one second (FEV,) after inhaled bronchodilators of less than 70% of predicted normal and
total lung capacity at least 80% of predicted nonnal. To be considered hypoxemic, a patient had to demonstrate either a partial
pressure of PaO, of less than 55 mm Hg or a PaO, of less than 59
mm Hg with either significant ankle edema or ECG evidence of
p-pulmonale. This degree of hypoxemia had to be maintained
for at least three weeks of infection-free clinical stability with
the patient on an intensive bronchodilator regimen.

Protocol summary
The following procedures were done within five days after the
three-week stabilization period: standardized history and physical
examination, sleep studies, quality of life questionnaires, neuropsychological tests, pulmonary function tests, hemodynamic
measurements, and arterial blood gas measurements. Medical
records were reviewed to document a history of hospitalization in
the year preceding the patient's entry into the study and to determine the reason for each hospitalization. Aspects of quality of life
were determined by two standard self-report questionnaires: the
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Profile of Mood States (11), which serves as a measure of current
mood; and the Sickness Impact Profile (12), which measures 12 categories of physical and psychosocial activities likely to be affected
by illness. The latter includes a sleep-rest category which contains
questions such as "1 sleep less at night, for example, wake up too
early, awaken frequently," and " I am sleeping or dozing most of the
time—day and night." During thefivedays in the hospital, patients
retired at their normal time and slept until their normal time of arising. Sleep studies were performed during one night of this hospitalization while the patients were breathing room air. All received a
theophylline preparation and an inhaled beta-adrenergic agonist,
and none received .sedative or psychotropic dmgs during the study.
Each patient gave informed consent to the study.
Sleep recordings
We performed the sleep studies by two separate methods. In
the first method, 25 of the patients selected consecutively from
two centers were studied in a fully equipped sleep laboratory.
The EEG was recorded with gold-plated surface electrodes applied at positions C,, C4, A,, and A, (according to the international lO-to-20 system) (13). Similar electrodes were applied
around the eyes to obtain the electrooculogram and under the
chin to obtain the electromyogram of submental muscles. The
impedance of the applied electrodes was measured with an electrode imoedance meter (Grass Instrument Co, Quincy, MA) and
was always less than 10 11. Other variables measured were
breathing pattern (using inductance pneumography or abdominal and chest strain gauges), SaO, (using a fiberoptic ear oximeter [Hewlett-Packard]), airflow detection at the nose and
mouth (using an infrared CO, analyzer, or thermistors), and an
ECG. The data were recorded on a multichannel polygraph at a
paper speed of 10 mm/sec. Awake SaO, was obtained during 15
minutes of supine wakefulness. Mean SaO, (referred to as basal
sleep SaO,) was obtained for a 30-second period every 2.5 minutes throughout the night. We recorded the number of times the
SaO, reached 10% less than the awake SaO,. The lowest SaO,
for the entire sleep period was also obtained.
The second method consisted of studying 105 subjects who
slept at night in a darkened room with a qualified observer in
constant attendance. Sleep was judged visually, and SaO, was
measured by afiberopticear oximeter (Hewlett-Packard) and recorded continuously on a single channel recorder. From these
records, similar measurements were made of awake, basal sleep,
10% dips, and lowest sleep SaO,. Although we tried to record at
least four hours of sleep, instrumentation prevented this in some
cases. All patients were judged to sleep for more than two hours
during the period they were observed.
Statistical analysis
Pairwise associations between variables were examined by
Pearson correlation coefficients or X" tests as appropriate. The
relationship between one variable and several others was examined by multiple regression analysis. Student's rtest was used to
test the equality of mean values between two groups. Mean values for two groups were compared after adjustment for a covariate by analysis of covariance (14). The survival experience for
two groups was compared by the log-rank test (15). In addition
to these inferential procedures, basic, descriptive information

Henry Ford Hosp Med J—Vol .36, No 1, 1988

Table 1
Clinical and Physiologic Characteristics of 130 Patients
with Hypoxemic Chronic Obstructive Pulmonary Disease
Sleep Recording Method
Nonpolygraphic
Polygraphic

Characteristics

Mean

SD

Mean

SD

Age (years)
PaO, (mm Hg)
PaCO, (mm Hg)
FEV|* (L)
Total sleep timet (minutes)
Awake supine SaO, (%)
Mean sleep SaO, (%)
Lowest sleep SaO, (%)
Sex (male/female)

66
51.7
42.2
0.75
195.5
86.2
83.2
69.1
83/22

8.5
4,4
7.2
0.3
40.3
4.6
6.9
13.6

66
52.4
44.7
0.7
256.1
87.8
82.9
69.0
20/5

8.8
4.5
8.2
0.4
93.4
4.7
7.2
13.2

*FEV| = forced expiratory volume in one second,
t p < 0.001; all other differences P > 0.1.

such as means and standard deviations were provided for the
most relevant variables.

Results
The 105 patients who underwent nonpolygraphic sleep studies and the 25 patients who were studied with complete polysomnography were similar in terms of pulmonary function and
degree of arterial oxygen desaturation during sleep (Table 1).
The mean total sleep time was one hour longer in the latter
group. Rapid eye movement (REM) sleep, recorded in 21 of
these 25 patients, accounted for 10% of their total sleep time.
Patients in both groups ranged in age from 41 to 84 years (mean
65.7 years) and weighed from 40 to 104 kg (mean 64.2 kg). They
had severe obstmctive lung disease with associated hypoxemia
and borderline hypercapnia. Their other characteristics were
similar to those previously recorded for patients enrolled in the
NOTT (10).
Terms and definitions
Desaturation was expressed as either basal desaturation
(awake SaO, minus mean sleep SaO,) or maximal desaturation
(awake SaO, minus lowest sleep SaO,). We separated the patients into severe and mild desaturation groups for both the basal
and maximal desaturation measures. The groups were defined
relative to the mean for both basal and maximal desaturation.
This arbitrary division allowed for approximately equal numbers in each group, yet recognized the clustering of patients
toward a mild degree of desaturation (Figs 1 and 2). The basal
desaturation during sleep exceeded 3% in 49 patients and was ^
3% in 81 patients. Maximal desaturation was ^ 17% in 53 patients and < 17% in 77 patients. A total of 66 patients had either
severe basal or severe maximal desaturation, but only half
(36/66) had severe abnormalities for both measures of desaturation. Because of this divergence, both measures of desaturation
were analyzed.
Degree of desaturation during sleep
The mean awake SaO, ± SD in 130 patients was 86.5% ±
4.7%. The mean basal desaturation was 3.4% ± 4.0% (Fig 1),
andthemeanmaximaldesaturationwas 17.4% ± 11.4%(Fig2).
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Fig 2—Distribution of maximal sleep desaturation abscissa:
chcinge in SaO-, from awake supine to the lowest during sleep.

Fig I—Distribution ofbasal sleep desaturation abscissa: change in REM sleep. Maximal desaturation occurred during REM sleep
SaO, from awake supine to the mean value during sleep.
in 21 of the patients who experienced this sleep stage. A more
detailed description of the sleep data in these 25 patients was
reported by Fleetham et al (16).
The maximal fall in SaO, recorded in a single patient during
sleep was 61%, and 11 patients experienced SaO, less than 50%
during sleep. All patients experienced desaturation at some time
during sleep (Fig 2). More frequent episodes of desaturation of
> 10% occurred in patients with severe desaturation. The mean
frequency of SaO, dips > 10% per night was 7.6 in patients with
severe maximal desaturation compared to 1 for patients with
mild maximal desaturation (P < 0.001). The frequency was 5.9
in those with severe basal desaturation and 2.5 if basal desaturation was mild (P < 0.02). In 67 patients, the mean sleep SaO,
was similar to or marginally greater than the awake SaO,. Although the severity of desaturation varied considerably in these
patients (Figs 1 and 2), the distribution was skewed in the direction of more severe desaturation. This abnormal distribution is
not solely due to the shape of the oxyhemoglobin dissociation
curve since the waking SaO, of most of our patients was at or
near the steep portion of the curve. This finding suggests that
some patients with COPD develop unusually severe desaturation
during sleep.
In 70% (92/130) of our patients, basal desaturation did not
occur or was < 4% (Fig 1), which indicates that a marked, prolonged depression in SaO, during sleep does not regularly occur
in COPD. However, at least one large dip in saturation occurred
commonly with 66% (86/130) of the patients, demonstrating a
maximal desaturation of greater than 10%.
No repetitive periods of apnea were observed in any of the
patients, nor was significant apnea documented polygraphically.
In the 25 patients who had polygraphic studies, the SaO, decreased from awake in all sleep stages but was severe only in
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Prediction of desaturation during sleep
To evaluate those factors that predict the degree of desaturation in sleep, both maximal and basal desaturation were correlated with clinical and laboratory data (Table 2). The most
significant relationship existed between awake PaCO, and both
measures of desaturation. The correlation was higher for maximal desaturation (r = 0.38, P < 0.001) than for basal desaturation (r = 0.26, P < 0.003). The awake PaO, correlated with
basal desaturation (r = -0.25, P<0.005)neariyaswellasthe
awake PaCO, but was not useful for predicting maximal desaturation. Based on multiple regression analysis, the combination of PaO, and PaCO, was not significantly more predictive of
basal and maximal desaturation than PaCO, alone.
No relationship existed between the degree of desaturation
and complaints of sleep disturbance which were provided by
analysis of individual questions or the overall sleep-rest scale of
the Sickness Impact Profile. There was also no relationship between degree of desaturation and the observations of troubled
sleep based on responses to the KATZ Adjustment Scale administered to relatives of the patients. Other clinical and laboratory
data were also unrelated to the degree of desaturation. These included age, sex, and weight as well as analysis of measures of
pulmonary function such as spirometry, airway resistance, functional residual capacity, and physicalfindingssuch as heart and
respiratory rate, wheezing and degree of edema, and the presence of cough or volume of sputum produced per day.
The relationship of PaCO, to both measures of desaturation
shows considerable scatter (Figs 3 and 4). Patients with low
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Fig 3—Relationship between waking PaCO, and basal desaturation during sleep in 130patients with hypoxemic COPD.

Fig 4—Relationship between waking PaCO2 and maximal
desaturation during sleep in 130 patients with hypoxemic COPD.

PaCO, tended not to desaturate. A PaC02 ^ 40 mm Hg had high
sensitivity but low specificity in predicting severe desaturation.
Of the patients with severe basal desaturation ( > 3%), 77%
(37/48) had a PaCO, 5* 40 mm Hg. However, of the patients
with mild basal desaturation ( « 3%), only 43% (35/82) had a
PaCO, < 40 mm Hg (Fig 3). The results are slightiy better for
predicting severe maximal desaturation (s^ 17%) with a sensitivity of 86.5% (45/52) and specificity of 50% (39/78) (Fig 4).
A low PaCO, may be a useful screening tool to indicate that an
individual is unlikely to develop severe desaturation during
sleep. However, even this test is not generally useful to reliably
ascertain the degree of desaturation at night.

Significance of sleep desaturation
We examined the complications of chronic hypoxemia to
determine if they were more severe when marked desaturation
occurred during sleep. A low but significant correlation (r =
0.30, P < 0.001) occurred between basal desaturation, but not
maximal desaturation, and the mean pulmonary artery pressure
at rest. A low correlation also occurred between the number of
hospitalizations in the year before the patients entered the study
and both measures of desaturation (r = 0.20, P < 0.03). No
relationship was observed between either measure of desaturation and hematocrit, maximal exercise tolerance, the results of
neuropsychological tests, or measures of the quality of life.

Table 2
Relationship Between Clinical and Laboratory Data and Desaturation During Sleep
Basal Desaturation

Maximal Desaturation

Characteristics
PaCO, (mm Hg)
PaO, (mm Hg)
pH
Age (years)
Weight (kg)
FVC (% predicted)
FEV, (% predicted)
SIP sleep-rest scale
(normal value = 2.1)

Sex
Male (N = 103)
Female (N = 27)

N

Mean

129
129
129
130
130
127
127

42.7
51.8
7.4
65.7
64.2
53.2
28.7

7.5
4.4
0.046
8.5
13.5
18.6
13.9

121

35.6

26.9

Correlation
Coefficient

SD

0.381
-0.104
0.151
-0.076
0.076
-0.115
-0.123

P
0.001
0.24
0.09
0.39
0.39
0.20
0.17

0.058
0.53
Maximal Desaturation
Mean
SD
P
17.1
18.7

11.3
11.7

0.52

Correlation
Coefficient
0.262
-0.252
-0.122
0.012
0.036
0.051
0.063

P
0.003
0.004
0.17
0.90
0.68
0.57
0.48

-0.095
0,30
Basal Desaturation
Mean
SD
P
3.2
4.3

3.8
4.6

0.19

FEV, = forced expiratory volume in one second. FVC = forced vital capacity, SIP = Sickness Impact Profile, and SD = standard deviation.
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Table 3
Effect of Nocturnal Desaturation on Complications of Chronic Hypoxemia

Characteristics
Number of patients
Gas exchange
PaO, (mm Hg)
PaCOj (mm Hg)
pH
Pulmonary hemodynamics
Mean pulmonary artery pressure at
rest (mm Hg)
Quality of life characteristics
Number of hospitalizations in year
prior to entry
Number of episodes of heart failure
in year prior to entry
Sickness Impact Profile (N = 3,1)
Profile of Mood States (N = 26,4)
Hematocrit (%)
Maximal exercise tolerance (WATTS)
Neuropsychological characteristics
Global rating (N = 3,5)
Halstead impairment index
(N = 0.63)
Cumulative survival (%)
Noctumal oxygen therapy
Continuous oxygen therapy

N*

Maximal Desaturation
Mild
Severe
< 17%
s= 17%
P
77

53

129
129
129

52.4
40.2
7.41

50.9
46.3
7.39

122

27.0

29.5

Mild
ss 3%

Basal Desaturation
Severe
> 3%

P

81

49

0.06
< 0.001
0.02

52.4
41.3
7.41

50.9
44.9
7.40

0.06
<0.01
0.31

O.IO

26.7

30.2

< 0.03

129

0.82

l.-i

< 0.003

0.98

1,2

0.28

129
120
118
]M)
129

0.32
23.7
38.8
47.7
38.0

0.62
24.7
37.7
47.8
40.6

0.04
0.70
0.86
0.90
0.42

0.43
23.8
38.7
47.5
38.3

0.47
24.7
37.7
48.3
40.2

0.78
0.73
0.87
0.41
0.56

123

4.2

4.4

0.35

4.2

4.4

0.30

1 IS

0.71

0.76

0.25

0.71

0.76

0.32

0.126
0.099

0.142
0.098

0.67
0.60

0.133
0.084

0.185
0.117

0.40
0.88

*N < 130 due to incomplete data.
All entries are mean values unless otherwise indicated.

To examine these relationships further, the severe and mild
desaturation groups were analyzed for differences in severity of
hypoxia-induced complications (Table 3). Pulmonary hypertension was more severe in patients with severe desaturation during
sleep (Table 3). This difference was significant only for the basal
desaturation determination. The mean pulmonary artery pressure in the group with severe basal desaturation was only 3.5
mm Hg higher than in those with mild basal desaturation. Although patients with severe maximal desaturation had less
severe abnormalities of pulmonary hemodynamics than patients
with severe basal desaturation, they had significantly more hospitalizations in the year preceding entry into the study. This was
due to more frequent hospitalizations for episodes ofrightheart
failure. No differences were noted in hospitalization rates or
heart failure between the patients with severe and those with
mild basal desaturation.
The severity of desaturation had no effect on other manifestations of chronic hypoxemia such as erythrocytosis, exercise intolerance, neuropsychological impairment as measured by the
Halstead-Reitan battery of tests, or the quality of life as measured by the Sickness Impact Profile and the Profile of Mood
States. There was also no effect on individual scales in each of
these tests.
The awake PaCO, was significantly higher in patients with severe desaturation, but this was well compensated, as manifested
by similar pH values in both groups. The hypercarbia resulted
in a slightly lower PaO, for patients with severe desaturation.
Because of these differences in waking blood gases, the effect of
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basal desaturation on pulmonary artery pressure was further examined by analysis of covariance to control for differences in
PaO, or PaCO,. After adjustments were made for waking
PaCO,, patients with severe basal desaturation still had significantly higher adjusted mean values for pulmonary artery pressure at rest (30 versus 26.9 mm Hg, P < 0.05). However, after
adjustments were made for waking PaO,, the adjusted mean pulmonary artery pressure at rest was 29.7 mm Hg in patients with
severe baseline desaturation and 27.1 mm Hg in those with mild
baseline desaturation (P < 0.08).

Effect of desaturation in selected patients
The effect of basal desaturation on waking pulmonary artery
pressure was determined in a group of 53 patients with a waking
PaO, between 54 and 59 mm Hg (Table 4). Of these, 15 had severe basal desaturation ( > 3%) and mean arterial blood gases
similarto the 38 with mild basal desaturation (=£ 3%). Their
mean pulmonary artery pressure was 3.7 mm Hg higher than
that of the patients with less severe noctumal desaturation, but
these differences were not significant in this group of patients.
In another group, 20 patients with the most severe noctumal
desaturation (basal desaturation > 6%) were compared to UO
patients with less severe desaturation (Table 4). Their mean PaO,
was similar to and the mean PaCO, was higher than that of
patients with less severe desaturation. Their mean pulmonary
artery pressure was significantly higher than that of the patients
with less severe nocturnal desaturation. No significant dif-
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Table 4
Effect of Nocturnal Desaturation on Pulmonary Hemodynamics
in Select Patient Populations
Very Severe Desaturation
Basal Desaturation
6%
> 6%
110
20

Waking PaO, 54-59 mm Hg
Basal Desaturation
3%
38
15

Characteristic

N

Number of patients
Gas exchange
PaO, (mm Hg)
PaCO, (mm Hg)
pH
Pulmonary artery
pressure at rest (mm Hg)

129
129
129

52.1
41.8
7.41

50.5
47.2
7.39

0.16
0.003
0.19

53
53
5.1

55.6
41.5
7.41

56.4
42.2
7.41

0.14
0.73
0.94

123

27.2

32.9

0.008

51

24.3

28.0

0.16

All entries are mean values unless otherwise indicated.

ferences in the severity of other hypoxia-induced complications
were found. The 25 polygraphically monitored patients were
analyzed separately. No significant correlations were found
between hypoxia-induced complications and either measure
of desaturation.
Mortality
The presence of severe desaturation in patients, obtained
while they were breathing room air, was not a predictor of subsequent mortality while they were receiving home oxygen therapy. This therapy included the use of oxygen during sleep in all
cases. Since the type of oxygen therapy has been shown to affect
mortality (10), before we calculated survival rates the patients
were separated into two groups based on the type of therapy they
were receiving (noctumal versus continuous). After a follow-up
period of at least 12 months (mean 19.3 months), the life table
cumulative survival rates were similar for patients with mild
and severe desaturation (Table 3). The initiation of treatment
would affect any influence that desaturation would have on mortality. This finding merely indicates that severe noctumal desaturation prior to therapy does not predict a poor response to
oxygen therapy.

Discussion
The degree of sleep arterial oxygen desaturation did not differ
between our two groups of patients with and without polygraphic recordings (Table 1). Although we did not document
sleep by EEG in all patients, it is reasonable to assume that these
patients did in fact sleep. For this reason, we believe the two
groups could be combined to examine relationships between
sleep desaturation and other physiological variables. Our patients slept an average of three to four hours, and 21 of the 25
polygraphically monitored patients demonstrated REM sleep.
These conditions are adequate to document typical sleep
desaturation in this population.
Complications of chronic hypoxemia such as erythrocytosis,
exercise intolerance, brain dysfunction, and impaired life quality as measured by standardized questionnaires were not aggravated by noctumal desaturation. Similarly, no relationship was
observed between the maximal desaturation during sleep and
waking pulmonary hypertension. Patients with severe maximal
desaturation also had more frequent SaO, dips > 10%. This in-
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dicates that these isolated physiologic challenges are of insufficient duration to produce permanent hemodynamic changes.
This is not surprising since these brief, dramatic events occur
exclusively in REM sleep which comprises a minor fraction (2%
to 5%) of the day for patients with COPD (16-18).
The mean level of SaO, prevailing throughout sleep is probably more relevant to the development of sustained pulmonary
hypertension since the pulmonary vasculature is exposed to this
SaO, for a longer period. This average desaturation throughout
sleep was examined as the basal desaturation. A correlation was
found between basal desaturation and pulmonary artery pressure. However, two factors should be considered in evaluating
this relationship and attempting to determine if there is an independent effect of basal desaturation on waking pulmonary
hypertension. The degree of basal desaturarion is related to
the waking PaO, (Table 2): the lower the waking PaO,, the more
severe the basal desaturation during sleep. Since all ofthese
patients had waking hypoxemia which could produce pulmonary hypertension alone, an independent effect of noctumal desaturation may be difficult to determine. The group with severe
basal desaturation (Table 3) had a mean waking pulmonary artery pressure only 3.5 mm Hg higher than that of the patients
with mild desaturation, but this difference was not significant after adjusting for the waking PaO, difference in these
two groups.
These results also apply to patients with moderate waking hypoxemia (PaO, 54 to 59 mm Hg). These patients would be
expected to be more susceptible to noctumal desaturation since
they have less pulmonary hypertensive stimulus during waking
hours. Finally, in the 20 patients with the most severe basal desaturation (> 6%), we found their mean pulmonary artery pressure to be significantly higher (5.7 mm Hg) than that of patients
with less severe desaturation. This suggests that at some degree
of severity nocturnal desaturation can aggravate hypoxemiainduced pulmonary hypertension.
The lack of a significant relationship between noctumal desaturation and waking pulmonary hypertension is surprising.
Numerous studies have confirmed that in awake patients with
COPD a close relationship exists between chronic hypoxemia
and pulmonary hypertension. By combining data from several
reports, Burrows (19) demonstrated that mean pulmonary artery
pressure progressively increases as waking SaO, falls below

Sleep Desaturation in Hypoxemic COPD—Conway et al

21

Table 5
Nocturnal Desaturation in Chronic Obstructive Pulmonary Disease

Reference
Flick and Block (4)
Wynne et al (5)
Douglas et al (6)
Littneret al (22)
DeMarco et al (23)
Calverly et al(18)
NOTT (10)

Number of
Patients
and Type
10 IPD
7 IPD/OPD
I2 0PD
9 0PD
4 BB
6 PP
13 BB
7 PP
130 OPD

IPD = hospitalized subjects, OPD
noctumal oxygen therapy trial.

Mean
Waking
SaO,

(%)
95
89
83
91
81
92
SO
94
86

Henry Ford Hosp Med J—Vol 36, No 1, !'-),XS

—
41)
53
42
4')
37
51
36
43

Mean
Maximal
Desaturation

Mean
Basal
Desaturation

(%)

(%)
—
—
—
—

26
17
30
15
30
5
41
16
17

3.2
0
9
2.1
3

ambulatory subjects. BB = "blue bloater," PP = "pink puffer," and NOTT =

85%. Moreover, periodic episodes of desaturation during sleep
in COPD (8,9) as well as in sleep apnea (20) have been shown to
produce transient increases in pulmonary artery pressure. It has
also been postulated that nocturnal desaturation may produce
sustained pulmonary hypertension and cor pulmonale (21), Although we did not measure pulmonary artery pressure during
sleep, the mean wake saturation of our patients was in the range
defined by a relationship between pulmonary hypertension and
SaO,. It is reasonable to assume that our patients with lower
SaO, during sleep had greater increases in pulmonary artery
pressure during sleep. However, our results show that transient
changes in saturation and associated pulmonary hypertension
during sleep usually do not produce chronic hemodynamic
changes in severe COPD beyond the effect attributable to the
daytime level of desaturation.
These results may not apply to noctumal desaturation in other
disorders such as sleep apnea and in COPD with borderline
hypoxemia (PaO, > 60 mm Hg). Since patients with these
disorders generally do not have a sustained pulmonary hypertensive effect during waking hours, they may be more susceptible
to chronic hemodynamic changes produced by basal desaturation during sleep. Nevertheless, our results indicate that
more work is necessary in this area before concluding that nocturnal desaturation alone will produce sustained pulmonary
hypertension.
Patients with severe maximal desaturation had more hospitalizations and episodes of right heart failure. These patients
also had more frequent dips in saturation greater than 10%. Transient episodes of pulmonary hypertension associated with these
dips might have had an adverse effect on right ventricular function that produced more severe right ventricular hypertrophy.
However, left ventricular dysfunction that produced greater
lability in noctumal saturation may have been more common in
patients with severe maximal desaturation. Since this group did
not have more severe waking pulmonary hypertension, this finding is difficult to explain.
Our results demonstrate that marked desaturation during
sleep is unusual in an unselected population of stable patients
with severe hypoxemic COPD. The mean basal desaturation was

22

Mean
PaCO,
(mm Hg)

only 3.4% ± 4.0%. This is a more comprehensive measure of
noctumal desaturation and indicates that desaturation throughout the night is less severe than previously indicated. The wide
difference between maximal and mean desaturation is due to serious desaturation occurring mostly in the brief periods of REM
sleep in this patient population (16). Maximal arterial oxygen
desaturation in our patients was comparable to that reported in
previous studies of patients with COPD (Table 5). In our study,
the mean maximal desaturation was 17.4% ± 11.4%, and earlier
reports of the mean maximal desaturation ranged from 5% to
41% (4-6,18,22,23). Since similar recording techniques were
used in all of these studies, the great variability in degree of
sleep arterial oxygen desaturation is probably related to
differences in patient population in terms of clinical stability,
severity of hypercarbia, and proportion of "blue bloater"type patients.
None of our patients demonstrated significant periodic apnea
or the characteristic features of the sleep apnea syndrome such
as hypersomnolence and frequent arousals (24). This is consistent with earlier reports (4-6,22) in which only two of 28 patients with COPD demonstrated significant obstmctive apnea,
but it conflicts with the data of Guilleminault et al (7) who found
significant apnea in 23 of 26 patients with COPD. However, the
unusual incidence of sleep apnea in their patients may be because they were referred primarily for evaluation of a sleep disorder and were unusually obese (mean weight 96 kg) for patients
with severe COPD.
Previous studies of sleep and breathing in normal subjects
have demonstrated that oxygen desaturation or irregular
breathing during sleep is more severe in men and increases with
age and weight (25-27). However, we found no such relationship
in our subjects, possibly because patients with severe obstructive lung disease are a more homogeneous group of elderly, thin
people. Only four patients were under 50 years old, and only 14
were greater than 130% of their ideal weight. Also, all except
one of our female patients were postmenopausal, and breathing
during sleep in postmenopausal women may be similar to that of
men (28). Complaints of sleep disturbance were also unrelated
to the degree of desaturation during sleep. Although these com-
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plaints were common among our patients, as confirmed by the
Sickness Impact Profile (sleep-rest scale, mean 35.6, normal
2.1), the disturbance was most likely caused by factors other
than desaturation, which could include coughing, hypercarbia
not associated with significant desaturation, effects of medication, and other chronic disease. Arousals in the patients are
common and often unassociated with significant desaturation,
which supports this explanation (16).
The awake PaO, and PaCO, were the only clinical or laboratory tests associated with sleep desaturation. Even these tests
were not reliable as a generally useful tool for predicting the degree of noctumal desaturation (Figs 3 and 4). The PaCO, relation
was a permissive one, that is, patients with low PaCO, usually
do not have severe desaturation, whereas patients with a higher
PaCO, may or may not have severe desaturation. Sleep desaturation has a similar relationship to the hypercapnic drive to breathe
(29). Patients with high hypercapnic drive generally do not have
large dips in SaO,. Those with low drive had either littie desaturation or severe desaturation, although all those with severe
desaturation had low drives. This is consistent with the notion
that low hypercapnic drives do not cause sleep desaturation but
permit the process which causes desaturation to occur.
In stable patients with chronic hypoxemia and severe COPD,
the following four conclusions can be made: 1) the mean nocturnal desaturation is mild in most patients; 2) desaturation during
sleep does not aggravate hypoxia-induced polycythemia, exercise intolerance, or neurophysiological impairment; 3) waking
pulmonary hypertension is increased by noctumal desaturation,
but this effect is clinically and statistically significant in only a
few patients with very severe decreases in mean saturation during sleep (> 6%); and 4) although the awake PaOj and PaCO,
were the only clinical parameters associated with sleep desaturation, even these tests were not reliable predictors of noctumal
desaturation; however, a low PaCO, indicates that severe
desaturation during sleep is unlikely.
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